Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial.
Saved in:
| Title: | Low-dose rivaroxaban plus aspirin in older patients with peripheral artery disease undergoing acute limb revascularization: insights from the VOYAGER PAD trial. |
|---|---|
| Authors: | Krantz MJ; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA.; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Debus SE; Department of Vascular Medicine, Vascular Surgery-Angiology-Endovascular Therapy, University of Hamburg-Eppendorf, Hamburg, Germany., Hsia J; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA., Patel MR; Duke Clinical Research Institute, Division of Cardiology, Duke University, Durham, NC, USA., Anand SS; Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, ON, Canada., Nehler MR; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA.; Department of Surgery, Division of Vascular Surgery, University of Colorado School of Medicine, Aurora, CO, USA., Hess CN; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA.; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Capell WH; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA.; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Bracken T; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA., Szarek M; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA.; SUNY Downstate Health Sciences University, 450 Clarkson Ave, Brooklyn, NY 11203, USA., Mátyás L; Borsod Central Teaching County Hospital., Krievins DK; University of Latvia, Latvia.; Pauls Stradins Clinical University Hospital, Vascular and Endovascular Surgery CISSSO, Gatineau, Québec, Canada., Nault P; McGill University, Canada., Stefanov S; City Clinic Cardiology Centre Multiprofile Hospital for Active Treatment EOOD., Haskell LP; Janssen Research and Development, Raritan, NJ, USA., Berkowitz SD; Thrombosis & Vascular Medicine, Clinical Development, Bayer U.S, Whippany, NJ, USA., Muehlhofer E; Bayer AG Research & Development, Pharmaceuticals, Wuppertal, Germany., Hiatt WR; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA.; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA., Bauersachs RM; Department of Vascular Medicine, Klinikum Darmstadt, Darmstadt, Germany.; Center for Thrombosis and Hemostasis, University of Mainz, Mainz, Germany., Bonaca MP; CPC Clinical Research, 2115 N Scranton Street, Suite 2040, Aurora, CO, USA.; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA. |
| Source: | European heart journal [Eur Heart J] 2021 Oct 14; Vol. 42 (39), pp. 4040-4048. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1522-9645 |
|---|---|
| DOI: | 10.1093/eurheartj/ehab408 |
